limited
1,5
four
trastuzumab
eligible
investigation
cm2
hormone
risk
activation
regional
replication
nodule
affect
examen
progression
induction
solution
force
resorption
direct
second
tangential
infiltration
even
reconstruction
new
net
neu
coefficient
cathepsin
residual
endothelium
localisation
108
protection
102
103
100
101
107
104
105
substance
study
permis
generale
inhibiteur
reste
projection
classification
treatment
visible
total
hospital
therefore
menopausal
type
mois
43
99
98
excellent
91
90
93
92
95
94
97
96
1991
1990
mg
1992
1995
1994
1997
1996
mm
1998
mo
work
iridium
unilateral
endometrial
end
provide
feature
adjacent
interview
nombre
translocation
synchrone
description
modulation
agarose
abdomen
tumeur
correlation
first
mastectomy
restriction
letrozole
interpretation
before
ligand
personal
production
400
maximal
then
them
deletion
remission
fragment
modification
therapy
they
fibrosis
choix
side
mean
interruption
progesterone
rt
gradient
steroidien
crucial
adhesion
infraclinique
perception
linear
creux
standard
formation
240
hand
publication
oppose
100000
signature
preoperative
already
grade
vitro
rank
175
atypique
efficacite
service
2
glucose
thoracic
symptom
p53
distance
target
zero
chimiotherapie
preparation
composante
23,7
acquisition
rat
seem
pleural
alors
faveur
blue
carcinome
carcinoma
phase
observation
medical
metal
anticancer
notion
reserve
d.
probe
soluble
analogue
latent
implementation
kinase
theme
adequate
do
above
di
cosmesis
degradation
report
vincristine
public
microscope
adherence
implication
fait
reference
peripheral
detection
result
oncogene
epithelium
score
approach
we
nature
confusion
lymphocyte
however
terme
cerb-2
linkage
improve
resistant
distinction
contribution
pregnancy
250
conference
abdominal
three
extraction
superieure
obese
life
gynecologique
168
conserve
fortement
160
exception
transformation
calcium
balance
procedure
concomitant
it
ii
border
make
recurrent
complex
phenotype
several
kit
metachrone
palpable
catheter
cycle
min
80%
contact
800
human
respectivement
yet
candidate
allele
elevation
fracture
survival
combination
possible
fusion
unique
desire
vertebral
59
58
55
54
57
56
51
50
53
52
specific
sous-groupe
right
old
indirect
dense
for
indication
participation
core
pose
menopause
substitution
cellulaire
post
limitation
predisposition
cadre
sept
presence
21.1
indispensable
initial
sternal
clinical
fraction
offer
m2
analyse
failure
docetaxel
renal
absent
maximum
vivo
emotional
150
152
154
abstract
evidence
expertise
radio-induite
physical
ni
nm
no
when
ne
ng
role
test
implant
node
variable
thorax
glass
interval
mitoxantrone
time
concept
bolus
tamoxifen
global
supplement
skin
inverse
depend
technique
passage
recurrence
0
charge
donnee
division
advantage
1993
choice
exact
minute
level
1999
ml
round
prediction
psychosocial
appear
assistance
seule
axial
suspect
phosphatase
international
boost
groupe
understanding
alone
change
sentinelle
trial
bon
usually
resonance
marker
etude
conservation
comparant
anastrozole
pratique
acceptable
apparent
craniocaudal
effort
pre-
cas
modifier
heart
figure
agent
sample
serum
monitoring
discussion
1
vital
optimal
146
147
product
140
sacrifice
spot
148
date
such
stress
joint
quadrant
cascade
si
so
block
representation
oncology
still
86
group
mais
organisation
suspicion
main
non
epidemiologique
exon
not
insulin-like
term
paclitaxel
domain
square
significantly
year
et
shown
increase
nominal
internet
correct
assurance
costal
postoperative
million
isotope
diagnostic
oligonucleotide
inevitable
methylation
place
promotion
support
frequent
1000
distal
one
directly
impossible
array
mammary
size
operable
plastic
stimulation
1b
cite
meme
similitude
way
that
transverse
echographique
trois
mastectomie
population
11
10
13
12
15
14
17
16
19
18
outcome
tumorectomie
correction
premier
argument
conversion
transcription
note
ideal
potential
deux
performance
impairment
lymphocytaire
200
multiple
trace
normal
incidence
molecule
hormonotherapie
especially
ailleurs
drive
28,6
show
femur
overexpressed
ratio
proportion
only
actin
membrane
dye
secondary
median
medial
irradiation
isodose
conservateur
college
surgery
vertical
3
parent
parental
facteur
article
cervical
reaction
22
aromatase
many
region
tout
expression
cancer
28
evaluable
period
60
61
pole
63
colon
65
66
traitement
68
69
seulement
intracanalaire
capable
incubation
500
direction
thousand
photon
external
geste
former
case
metastase
situation
margin
lobulaire
endothelial
orientation
prevalence
telephone
multifocale
cluster
protein
technology
different
pas
participant
ecart-type
same
surveillance
microarray
status
statut
estimation
faible
severe
penetration
dimension
taille
stroma
aspect
differentiation
univariate
adjuvant
improvement
instrument
4
stade
specimen
early
inhibition
preference
satisfaction
ductal
62
drainage
64
dilution
3000
simulator
67
sentinel
respect
questionnaire
definir
critical
equivalent
dissection
tumour
central
therapeutique
tumor
degre
act
ou
protease
inclusion
implantation
communication
image
cyclophosphamide
involvement
survie
intervention
radiology
log
her
area
there
strict
detectable
low
lot
secretion
energy
tyrosine
project
complete
regard
posterior
lymph
elimination
with
circulation
600
certain
al
deep
general
hypertension
follow-up
film
pmol
personnel
depth
field
5
spatial
prise
deviation
collaborative
radiotherapie
disease-free
important
pool
bilateral
excretion
mass
oral
original
represent
all
month
surgical
systemic
infiltrant
equivalence
overlying
presentation
al.
very
fat
difference
condition
deficient
evaluation
list
applicable
phosphorylation
t1
large
small
biological
programme
entourage
199
rate
design
perspective
further
hormonal
section
thickness
version
method
amplification
invasif
toxicite
experience
amount
social
action
family
marginal
cosmetic
utilisation
select
distinct
polype
two
85%
automate
6
flap
emission
discordance
gauche
soit
der
remain
taux
male
history
radiotherapy
sphere
minimum
concordant
scar
transduction
information
rather
rapport
antiaromatase
cytokine
exemestane
prognostic
mapping
invasion
horizontal
response
maligne
short
randomised
help
administration
oblique
attitude
existence
visceral
24
25
26
27
20
21
symptome
23
susceptible
lateral
selenium
29
late
absence
oncologist
2+
good
food
primary
association
mammographique
stopper
coping
micro
inherent
cinq
mental
generation
fish
reduce
mm2
measurement
operation
item
research
health
7
issue
caspase
reason
base
depistage
definition
accumulation
consequence
controlaterale
major
radical
mise
number
donc
similaire
temperature
introduction
180
least
regulation
responsable
185
molecular
schema
ainsi
relationship
needle
basal
part
favorable
diffusion
incision
double
systematique
aussi
defect
concentration
option
jour
depending
lin
majorite
also
internal
depression
suivi
77
76
75
74
73
plan
71
70
alpha
79
78
kg
mineral
mobile
significatif
postmenopausal
apres
particularly
gold
relation
fine
impact
recidive
enzyme
factor
8
his
dominant
cote
mieux
generally
alteration
maniere
common
body
set
sex
culture
see
individual
metastatique
arm
notamment
expert
canalaire
vascular
probably
available
recently
effet
targeted
attention
incident
interface
tres
recherche
prescription
caractere
long-term
whole
experimental
point
simple
adaptation
vessel
moins
complication
reduction
initiation
pg
meeting
ganglion
pulmonaire
39
cranial
determination
technical
guide
30
gel
particulier
anthracycline
randomisation
colorectal
9
neoadjuvant
composition
development
attenuation
fibrose
moment
user
opinion
calcification
focal
recent
lower
analysis
organization
self
prevention
alternative
cut
5,3
source
difficile
taxane
couple
axillary
pertinent
signal
consensus
nipple
disorder
creation
peu
decision
integration
2,3
curage
minimal
be
patient
300
bp
30%
simulation
gamma
72
controlateral
drain
realisation
pathologie
luminal
question
long
consultation
an
serie
injection
considerable
excision
characteristic
up
us
exploration
verification
similar
fluence
constant
estrogen
influence
quantification
single
cure
application
genome
suppression
structure
antecedent
lead
fluorescence
age
2002
2003
2000
2001
2006
2007
2004
2005
tube
code
partial
resistance
essai
discordant
compose
stable
suite
mutation
confirmation
electron
sensitivity
surgeon
transmission
antigen
sensation
tumoral
insertion
fonction
index
randomise
cell
mammography
cf.
proliferation
commercial
separation
consideration
extreme
great
38
survivor
33
32
31
inoperable
37
36
35
34
3+
diagnostique
gene
pronostic
decrease
2,6
repopulation
perfusion
few
camera
examination
stage
sort
trait
infection
train
iii
resection
challenge
inhibitor
control
0.5
0.4
risque
high
origine
syndrome
six
prognosis
animal
histologique
souvent
tension
lesion
probablement
estrone
collection
brachytherapy
prostate
element
montre
allow
breast
133
130
135
superior
longitudinal
exclusion
la
permanent
biomedical
histological
mammaire
rotation
mode
lung
tracer
frequence
society
88
89
82
our
80
81
sexual
87
84
85
cerebral
cause
clone
red
interaction
adolescent
route
length
scarf
prospective
quality
management
observer
system
their
chemotherapy
final
tissu
institution
epidermal
patiente
aspiration
bed
temoin
defense
reproduction
comparaison
encore
migration
clip
have
need
demonstration
angle
quartile
stromal
able
mechanism
contour
ganglionnaire
pivotal
which
competence
serine
centre
collaboration
precoce
segment
dorsal
disease
face
suture
selection
planning
principal
based
knowledge
terminal
locoregional
controle
bisphosphonate
local
inferior
peptide
overall
120
beam
125
familial
128
litterature
gray
evolution
organ
partir
contain
view
national
accord
centrifugation
wire
pattern
identification
routine
comparable
importance
traduction
distribution
drug
placebo
comment
recemment
cm
wall
invasive
diminution
seuil
table
scanner
addition
genetic
monoclonal
determinant
corresponding
retrospective
acetate
repetition
present
laser
externe
motif
axillaire
site
surface
partner
regression
radiation
adverse
difficult
premiere
effect
student
variance
moyen
destruction
concordance
center
well
chemokine
position
muscle
subgroup
echographie
seul
dose
distant
coordination
femme
rapid
absorption
etre
resultat
saturation
five
log-rank
loss
become
page
therapeutic
accessible
poor
deuxieme
sequence
115
endometriale
117
growth
110
112
119
118
transport
tamoxifene
avoid
overlap
inflammation
estradiol
multifocal
journal
expansion
fluorescent
panel
rare
extension
compatible
stratification
receptor
female
clinique
mammographie
1986
1987
1984
1985
van
1983
1980
marqueur
1988
1989
intention
function
volume
construction
gain
he
evident
below
problem
piece
sein
periode
dissemination
revanche
epithelial
83
education
chromosome
caspase-3
48
49
46
47
44
45
42
detail
40
41
chirurgical
other
predominant
conclusion
variation
precision
chance
macrophage
prevalent
niveau
resolution
egalement
diagnosis
validation
